Sponsor or institution

Clinical trials and research at Hospital Authority, Hong Kong

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Hospital Authority, Hong Kong that are recruiting, in Hong Kong. By phase: Phase 4 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Nurse-led telehealth versus in-person follow-up after total knee replacement — Hong Kong Recruiting Jul 10, 2025
Quarterly faricimab maintenance for neovascular age-related macular degeneration Phase 4 Hong Kong Recruiting Dec 19, 2024
Topical Ruxolitinib for treating vitiligo in adults Phase 2/3 Hong Kong Recruiting Dec 5, 2024
Testing SGLT2 inhibitors for treating sepsis in adults — Hong Kong, Hong Kong and 2 other locations Recruiting Jun 25, 2024

All recruiting trials (4)

Quick answers

How many clinical trials run by Hospital Authority, Hong Kong are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Hong Kong. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.